Active immunotherapy oncolytic virus therapy using HSV-1

T Todo - Glioma: Immunotherapeutic Approaches - Springer
Conditionally replicating herpes simplex viruses Type 1 (HSV-1) are promising therapeutic
agents for glioma. They can replicate in situ, spread and exhibit oncolytic activity via a direct …
被引用次数：38 相关文章

Active Immunotherapy Oncolytic Virus Therapy Using HSV-1

T Todo - Glioma: Immunotherapeutic Approaches - Springer
Conditionally replicating herpes simplex viruses Type 1 (HSV-1) are promising therapeutic
agents for glioma. They can replicate in situ, spread and exhibit oncolytic activity via a direct …

Active immunotherapy: oncolytic virus therapy using HSV-1.

T Todo - Advances in Experimental Medicine and Biology, 2012 - europepmc.org
Conditionally replicating herpes simplex viruses Type 1 (HSV-1) are promising therapeutic
agents for glioma. They can replicate in situ, spread and exhibit oncolytic activity via a direct …

[引用][C] Active Immunotherapy Oncolytic Virus Therapy Using HSV-1

T Todo - Advances in Experimental Medicine and Biology, 2012 - cir.nii.ac.jp

Active immunotherapy: oncolytic virus therapy using HSV-1

T Todo - Advances in experimental medicine and biology, 2012 - pubmed.ncbi.nlm.nih.gov
Conditionally replicating herpes simplex viruses Type 1 (HSV-1) are promising therapeutic
agents for glioma. They can replicate in situ, spread and exhibit oncolytic activity via a direct …

[引用][C] Active Immunotherapy Oncolytic Virus Therapy Using HSV-1

T Todo - Glioma, 2012 - Springer